Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 6/24/20 → 3/14/22 |
Financiación
- AbbVie Incorporated: 33.824,00 US$
A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke
- Hatton, Kevin (PI)
- Lee, Jessica (CoI)
- Swafford, Kara (CoI)